
We work with pioneering businesses at the forefront of innovation and impact, helping them raise capital, navigate acquisitions and scale.
Selected Clients
Fundraise
Salinity Solutions
WaterTech
Salinity Solutions is tackling two growing global challenges: water scarcity and the rising demand for critical minerals such as lithium. Its patented HyBatch reverse osmosis technology enables higher water recovery and more efficient treatment, with applications across lithium extraction, desalination and industrial water reuse. By helping industries recover more water while reducing waste and environmental impact, the technology has the potential to transform how water and valuable resources are managed.
Fundraise
Carbon ThreeSixty
Industrial Innovation
Carbon ThreeSixty is transforming advanced manufacturing through lightweight, high-performance composite structures that help industries improve efficiency and reduce material use. Its advanced composite technologies are used across automotive, aerospace, defence and electric power applications, helping reduce weight, improve energy efficiency and increase performance. By combining advanced materials with scalable manufacturing, Carbon ThreeSixty is supporting the transition towards more efficient and lower-carbon industrial and transport systems.
Fundraise
Chorus
Future Of Work
Chorus is a SaaS platform helping safety-critical and high-hazard industries manage learning, compliance and workforce competence in one place. By replacing fragmented systems and manual processes with a single, audit-ready platform, Chorus gives organisations greater visibility over workforce readiness, helping them reduce risk, simplify compliance and ensure people have the skills needed to operate safely.
M&A Sell-side
Net Zero Now
ClimateTech
Net Zero Now is a climate action platform that helps businesses measure, reduce and report their Scope 1, 2 and 3 emissions through sector-specific carbon measurement, reduction and certification solutions. Its industry-led approach provides businesses with a practical and credible pathway to achieving Net Zero.
Fractional CFO
Lambda Energy
Clean Energy
Lambda Energy is a clean energy company developing innovative solar technology for agricultural environments, enabling growers to generate renewable energy while maintaining productive growing conditions. Its technology sits at the intersection of renewable energy, agriculture and sustainable food production.
Fractional CFO
Opus Cactus
AgriTech
OPUS Cactus is an agri-tech and bioenergy company developing solutions from cactus biomass across low-carbon energy, animal feed and high-value bio-based products. Its approach combines agricultural innovation with opportunities for land regeneration, carbon sequestration and resource efficiency.
Fundraise
Terrafend
CleanTech
Terrafend is transforming industrial cleaning with its patented Ambimization® technology, providing a high-performance alternative to traditional cleaning methods that rely on harmful solvents and chemicals. Its proprietary water-based solutions are designed to be non-toxic, non-carcinogenic, non-flammable and low in VOCs, enabling industries to move towards cleaner, safer and more sustainable operations. The technology is already helping businesses reduce waste and emissions while supporting the transition towards a more circular economy.
Fractional CFO
Polysolar
Clean Energy
Polysolar develops advanced photovoltaic technology that integrates renewable energy generation into buildings and infrastructure. Its transparent solar solutions can be incorporated into applications such as commercial buildings, transport infrastructure and solar canopies, turning underutilised surfaces into sources of clean energy.
Fundraise
Nevrargenics
Life Sciences
Nevrargenics is a UK neuroscience company developing novel small-molecule therapies for neurodegenerative diseases including ALS, frontotemporal dementia, Parkinson’s and Alzheimer’s. Its lead programme uses dual-acting retinoic acid receptor modulators designed to protect neurons, support neuroplasticity and potentially modify disease progression.










